Is Parnax Lab Ltd halal to invest in?

As of July 2026, Parnax Lab Ltd 506128.BO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Parnax Lab Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parnax Lab Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Parnax Lab Ltd?

Muslim investors may consider investing in Parnax Lab Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Parnax Lab Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Parnax Lab Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Parnax Lab Ltd updated?

The Shariah compliance status of Parnax Lab Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Parnax Lab Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Parnax Lab Ltd?

You can check the latest Shariah compliance status of Parnax Lab Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Parnax Lab Ltd 506128.BO

Last Updated: Jul 17, 12:00 AM·BSE

506128.BO Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Parnax Lab Ltd is classified as not halal.

NOT HALAL

Report Source: 2026 2nd Quarter Report

Parnax Lab Ltd. Stock Analysis 506128.BO

India Health Care Nano Cap Report: Q2, 2026

Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. The company is headquartered in Mumbai, Maharashtra and currently employs 12 full-time employees. The company went IPO on 2009-09-15. The firm is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The firm operates through the trading of the pharmaceuticals and medicinal products segment. The company is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The firm provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.

Key Statistics of Parnax Lab Ltd (506128.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹147.10₹152.00

Today's Open

₹147.60

Volume

2054.00

P/E Ratio (TTM)

12.73

52 Week Range

₹96.25₹182.00

Market Cap

1.56B

Avg. Volume

6561.86

Dividend Yield

Financial Metrics & Statements of Parnax Lab Ltd (506128.BO)

Super Investors Invested in Parnax Lab Ltd (506128.BO)

FAQ's for Parnax Lab Ltd (506128.BO)

As of July 2026, Parnax Lab Ltd 506128.BO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parnax Lab Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Parnax Lab Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Parnax Lab Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Parnax Lab Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Parnax Lab Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.